VIRONIX

Mark For: VIRONIX® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of AIDS, cancer, auto-immune diseases, neurological diseases, cardio-vascular diseases, arthritis and senescence; pharmaceutical preparations for preventing and treating diseases by gene therapy; vaccines; diagnostic preparations and biological and bacteriological reagents for clinical or medical use. [all]

Status

2022-08-15 UTC
⟳ Refresh

DEAD REGISTRATION Cancelled Invalidated

Research	OneLook Acronym Finder
Serial Number	76318464
Registration Number	2680169
Mark Literal Elements	VIRONIX
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	TRADEMARK. SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	SCANNING ON DEMAND 2008-05-19
Basis	44(e)
Class Status	SECTION 8 - CANCEL
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	Yes
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Domestic Representative	Raymond O. Linker, Jr.
Attorney Name	Raymond O. Linker, Jr.
Attorney Docket Number	033339-23949
Law Office Assigned	M70
Employee Name	SNAPP, TINA LOUISE

Timeline

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of AIDS, cancer, auto-immune diseases, neurological diseases, cardio-vascular diseases, arthritis and senescence; pharmaceutical preparations for preventing and treating diseases by gene therapy; vaccines; diagnostic preparations and biological and bacteriological reagents for clinical or medical use(CANCELLED)
IC 042. US 100 101. G & S: Chemical analysis and laboratory work; pharmacy research, biotechnology and gene therapy research, bacteriological research, medical research